Cancer drug margin cap could shift costs elsewhere in India’s hospitals

A 30% cap on trade margins for 137 non-scheduled cancer drugs could cut prices sharply, but hospitals and industry experts warn that revenue may be recovered through separate charges for services and diagnostics. India’s move to cap trade margins at…















